What Researchers Did
This systematic review examined randomised controlled trials to determine the effectiveness and safety of hyperbaric oxygen therapy (HBOT) as an additional treatment for acute ischaemic stroke.
What They Found
Researchers identified three randomised controlled trials involving 106 participants that compared HBOT to no HBOT for acute ischaemic stroke. The review found no significant differences in clinically important outcomes between the groups receiving HBOT and those who did not.
Canadian Relevance
No direct Canadian connection identified. Acute ischaemic stroke is not a Health Canada-recognised indication for hyperbaric oxygen therapy.
Study Limitations
The review was limited by the small number of included trials and participants, making it difficult to draw strong conclusions about HBOT for acute ischaemic stroke.